Showing results (71-80 of 617) with videos related to

Sort By:
Pageof 62
Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2017
SOHO State-of-the-Art Update and Next Questions: MPNPrithviraj Bose, Jason Gotlib, Claire N Harrison, et al.
International Orthopaedics|October 21, 2003
The periprosthetic bone remodelling process--signs of vital bone reactionArnim Braun, Jan Papp, Andreas Reiter
Acta Haematologica|June 5, 2004
Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemiaAndreas Reiter, Eva Lengfelder, David Grimwade
Frontiers in Immunology|June 29, 2026
Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseasesJohannes Lübke, Andreas Reiter, Juliana Schwaab
The Journal of Allergy and Clinical Immunology|April 14, 2022
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?Peter Valent, Cem Akin, Karin Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
British Journal of Clinical Pharmacology|December 12, 2018
Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modellingJennifer E Hibma, Hagop M Kantarjian, Daniel J DeAngelo, et al.
Histopathology|March 7, 2017
Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissuesJacqueline M Cortazar, Daniel J DeAngelo, Geraldine S Pinkus, et al.
Pageof 62